Loading interface...

Properol 1 MG Injection

Manufactured bySamarth Life Sciences Pvt. Ltd.
ContainsPropranolol
Description
Properol 1 MG Injection is used for the treatment of irregular heartbeats which may be life-threatening or those occurring under anesthesia.

Side effects

Major & minor side effects for Properol 1 MG Injection

  • Dizziness and lightheadedness
  • Diarrhea
  • Difficulty in breathing
  • Skin blistering
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Pain at the injection site
  • Weight gain
  • Skin rash, hives, or itching
  • Tiredness and weakness

Uses of Properol 1 MG Injection

What is it prescribed for?

  • Arrhythmias
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 2 to 10 minutes of administration.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use during pregnancy unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to Propranolol or any other inactive ingredients present along with the formulation.

Uncompensated congestive heart failure

This medicine is not recommended for use in patients who have uncompensated congestive heart failure due to the increased risk of worsening of the patient's condition.

Cardiogenic shock

This medicine is not recommended for use in patients with cardiogenic shock due to the increased risk of worsening the patient's condition.

Lung diseases

This medicine is not recommended for use in patients suffering from lung diseases like asthma, bronchospasm, and chronic obstructive pulmonary disease (COPD).

Severe bradycardia

This medicine is not recommended for use in patients with severe bradycardia (slow heart rate than normal) due to the increased risk of worsening the patient's condition.

Heart block greater than first degree

This medicine is not recommended for use in patients with second or third-degree heart block due to the risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use during pregnancy unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Allergy

This medicine should be used with caution in patients with seasonal allergies or allergies to specific food substances since it may increase the severity and frequency of the allergies. Report any unusual symptoms to the doctor immediately. Replacement with a suitable alternative may be required based on the clinical condition.

Hyperthyroidism

This medicine should be administered with caution in patients suffering from hyperthyroidism since it may mask some of the patient's symptoms. Report any unusual symptoms to the doctor immediately. You may require a dose adjustment and more frequent clinical monitoring to safely use this medicine. Do not stop the use of this medicine without consulting your doctor.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Amlodipine

Diltiazem

Lidocaine

Aminophylline

Formoterol

Epinephrine

Nonsteroidal anti-inflammatory medicines

Disease interactions

Asthma

This medicine is not recommended for use in patients with a history of bronchial asthma or chronic obstructive pulmonary disease since it may worsen the patient's condition. Replacement with a suitable alternative should be done under your doctor's supervision.

Psoriasis

This medicine should be used with caution in patients suffering from psoriasis due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Diabetes

This medicine should be used with caution in patients with diabetes mellitus due to the increased risk of altered blood glucose levels. Close monitoring of blood glucose levels is advised for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Glaucoma

This medicine should be used with caution in patients suffering from glaucoma due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Liver disease

This medicine should be used with caution in patients suffering from mild to moderate liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition. It is not recommended for use in patients with severe liver impairment.

Hyperlipidemia

This medicine should be used with caution in patients with hyperlipidemia due to the increased risk of altered lipid levels in the body. Regular monitoring of lipid profiles, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney disease

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by relaxing the blood vessels and reducing the heart rate.
Legal Status

Approved

Approved

Unknown

Unknown

Classification

Category

Group II antiarrhythmics, Non-cardioselective beta blockers

Schedule

Schedule H

Propranolol | C16H21NO2 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 15 March 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/4946#section=Top

Propranolol - DrugBank [Internet]. Drugbank.ca. 2017 [cited 31 October 2017]. Available from:

https://www.drugbank.ca/drugs/DB00571

DailyMed - Propranolol - propranolol hydrochloride injection, solution [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 22 May 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f14ea537-dd5c-4c78-9037-9a85e9e610ef
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 22 May 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.